Stay updated on Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial page.

Latest updates to the Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added and the notice about government funding lapse, as well as Revision: v3.4.1, were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded an operating status notice about government funding and released Revision: v3.4.1, while removing Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check28 days agoChange DetectedThe history page now includes a glossary toggle and color-coded indicators for additions (green) and deletions (red). Revision metadata updated to v3.4.0 and the No FEAR Act data label standardized.SummaryDifference0.4%

- Check42 days agoChange DetectedThe page history now shows Revision: v3.3.4, replacing the previous v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page now shows Revision: v3.3.3, and the HHS Vulnerability Disclosure link along with the older Revision: v3.3.2 entry were removed.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 was removed from the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial page.